Literature DB >> 1730115

Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study.

M Ponz de Leon1, M Sant, A Micheli, C Sacchetti, C Di Gregorio, R Fante, G Zanghieri, G Melotti, G Gatta.   

Abstract

The institution of a colorectal Cancer Register in a health care district of Northern Italy gave the authors the opportunity to evaluate the prognostic relevance of several morphologic and clinical variables by univariate and multivariate analyses. Of the 134 patients registered in 1984, 132 were followed up until the end of 1989. Overall 5-year survival was 37%, but the figure increased to 43% when only colorectal cancer-related deaths were considered. Univariate analysis for clinical variables showed that TNM staging and age at diagnosis were significantly related to prognosis, whereas none of the other parameters were indicative of the clinical outcome. With a similar analysis, among the various morphologic variables, pattern of growth (infiltrating versus expanding) and extent of fibrosis (extensive versus little or absent) appeared to be indicators of prognosis. When the variables that were significant (stage, age, pattern of growth, and fibrosis) in the univariate analysis were entered into the Cox model of multivariate analysis, TNM staging was the only parameter that maintained an independent prognostic importance. The authors state that their results confirm the importance of stage in predicting survival for cancer of the large bowel and suggest that the possible prognostic value of clinical and morphologic variables should be investigated within each of the major TNM or Dukes' classes.

Entities:  

Mesh:

Year:  1992        PMID: 1730115     DOI: 10.1002/1097-0142(19920201)69:3<626::aid-cncr2820690305>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Nodal spread and micrometastasis within mesorectum.

Authors:  Cun Wang; Zong-Guang Zhou; Zhao Wang; Dai-Yun Chen; Yang-Chun Zheng; Gao-Ping Zhao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.

Authors:  Carmela Di Gregorio; Piero Benatti; Lorena Losi; Luca Roncucci; Giuseppina Rossi; Giovanni Ponti; Massimiliano Marino; Monica Pedroni; Alessandra Scarselli; Barbara Roncari; Maurizio Ponz de Leon
Journal:  Int J Colorectal Dis       Date:  2004-12-09       Impact factor: 2.571

3.  Ten-year survival of patients with cancer of the digestive tract in Umbria, Italy.

Authors:  F La Rosa; A M Petrinelli; L Minelli; V Mastrandrea
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 4.  Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature.

Authors:  Carmela Di Gregorio; Luca Reggiani Bonetti; Carmela de Gaetani; Monica Pedroni; Shaniko Kaleci; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2012-03-27       Impact factor: 3.397

5.  Symptom-to-diagnosis interval and survival in cancers of the digestive tract.

Authors:  Esteve Fernandez; Miquel Porta; Núria Malats; Josep Belloc; Manuel Gallén
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

6.  Role for gender in colorectal cancer risk: a Taiwan population-based study.

Authors:  Chia-Lin Chou; Shih-Feng Weng; Jen-Kou Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2013-02-01       Impact factor: 2.571

7.  Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases.

Authors:  Nobuaki Higashi; Hideki Ishii; Takeshi Fujiwara; Megumi Morimoto-Tomita; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Authors:  Pradipta Ghosh; Jeanne Tie; Andrea Muranyi; Shalini Singh; Patrick Brunhoeber; Katherine Leith; Rebecca Bowermaster; Zhiming Liao; Yifei Zhu; Bonnie LaFleur; Ben Tran; Jayesh Desai; Ian Jones; Matthew Croxford; Rodrigo Jover; Ajay Goel; Paul Waring; Song Hu; Volker Teichgraber; Ulrich-Peter Rohr; Ruediger Ridder; Kandavel Shanmugam; Peter Gibbs
Journal:  Clin Cancer Res       Date:  2016-03-30       Impact factor: 12.531

9.  Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.

Authors:  Mahdi Montazer Haghighi; Ramin Radpour; Katayoun Aghajani; Narges Zali; Mahsa Molaei; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2009-05-29       Impact factor: 2.571

10.  Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

Authors:  Ali Ilker Filiz; Ilker Sucullu; Yavuz Kurt; Dursun Ozgur Karakas; Bulent Gulec; Mehmet Levhi Akin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.